Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-22-007912
Filing Date
2022-02-25
Accepted
2022-02-25 17:02:37
Documents
1
Period of Report
2022-02-23

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3866
  Complete submission text file 0000899243-22-007912.txt   5540
Mailing Address 300 NORTH BEACON STREET SUITE 501 WATERTOWN MA 02472
Business Address 300 NORTH BEACON STREET SUITE 501 WATERTOWN MA 02472 617-679-1970
Forma Therapeutics Holdings, Inc. (Issuer) CIK: 0001538927 (see all company filings)

EIN.: 371657129 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O FORMA THERAPEUTICS HOLDINGS, INC. 300 NORTH BEACON STREET SUITE 501 WATERTOWN MA 02472
Business Address
Lesser Brian Andrew (Reporting) CIK: 0001894291 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39333 | Film No.: 22681597